Full-body MRI screening

The evidence base does not support the healthspan claims made for whole-body MRI as a screen for asymptomatic, average-risk adults. There is no randomised trial showing that whole-body MRI screening of unselected asymptomatic adults reduces all-cause or cancer-specific mortality. Where MRI screening does have real support, it is in defined high-risk groups (for example hereditary cancer predisposition surveillance), which is a different population and a different indication from the consumer longevity product. The documented harms are substantial and well characterised: a high rate of incidental findings, most of which are benign, driving downstream imaging, biopsy, and invasive workup, plus overdiagnosis and anxiety. Everlab's own product page concedes this, stating that for average-risk individuals the research is ongoing and that the role of whole-body MRI as a broader screening tool in asymptomatic average-risk adults "remains less clearly established", and that the scan is not a reliable screen for breast, colon, or prostate cancer, with ovaries difficult to assess. Note: this profile was compiled without live literature search (the session's web search budget was exhausted), so the evidence characterisation above rests on the vendor page retrieved plus the discovery brief, not on independently retrieved trial or guideline sources. Treat the evidence grading as directionally reliable but not source-complete.

What it is

Plain-language explainer

Categories

Common questions

What is Full-body MRI screening?

The evidence base does not support the healthspan claims made for whole-body MRI as a screen for asymptomatic, average-risk adults. There is no randomised trial showing that whole-body MRI screening of unselected asymptomatic adults reduces all-cause or cancer-specific mortality. Where MRI screening does have real support, it is in defined high-risk groups (for example hereditary cancer predisposition surveillance), which is a different population and a different indication from the consumer longevity product. The documented harms are substantial and well characterised: a high rate of incidental findings, most of which are benign, driving downstream imaging, biopsy, and invasive workup, plus overdiagnosis and anxiety. Everlab's own product page concedes this, stating that for average-risk individuals the research is ongoing and that the role of whole-body MRI as a broader screening tool in asymptomatic average-risk adults "remains less clearly established", and that the scan is not a reliable screen for breast, colon, or prostate cancer, with ovaries difficult to assess. Note: this profile was compiled without live literature search (the session's web search budget was exhausted), so the evidence characterisation above rests on the vendor page retrieved plus the discovery brief, not on independently retrieved trial or guideline sources. Treat the evidence grading as directionally reliable but not source-complete.

How strong is the evidence for Full-body MRI screening?

Commercial. It is offered and sold, which is a statement about availability, not about efficacy.

Is Full-body MRI screening approved in Singapore?

variis has no Health Sciences Authority position on file for Full-body MRI screening. Absence of a recorded position is not approval.

Is Full-body MRI screening approved in Australia?

variis has no Therapeutic Goods Administration position on file for Full-body MRI screening. Absence of a recorded position is not approval.

Which clinics offer Full-body MRI screening?

1 clinic in the variis directory across Singapore and Australia has Full-body MRI screening on record. Each is listed on this page with its own sourced profile.

What else is Full-body MRI screening called?

Also known as Whole-body MRI, Whole-body screening MRI, Full body scan, Full body MRI + CT chest.